Insider screener

Period: 12 months + Add filter
Saved screens

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

60,080 decisions over 12 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

60,080 decisions over 12 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

60,080 decisions over 12 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

60,080 decisions over 12 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
60,080 decisions over 12 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
60,080 decisions over 12 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

60,080 decisions over 12 months
Stock
Insider
Type ?
Why it stands out
17 Jul 2026
BOUDREAUX GAIL President and CEO
Bought 2×
$1.00M 2,725 at 367.79
1.6%
17 Jul 2026
Sold on a plan
$949.50K 24,999 at 37.98
0.6%
Planned (10b5-1)
17 Jul 2026
Aqua Capital, Ltd. 10% owner
Bought 2×
$819.38K 40,000 at 20.48
0.5%
17 Jul 2026
Zeidel Darren General Counsel
Sold on a plan 3×
$725.50K 1,950 at 372.05
12.7%
Planned (10b5-1)
17 Jul 2026
GILLIS JONATHAN CAO and Interim CFO
Sold on a plan 3×
$694.46K 18,469 at 37.60
11.4%
Planned (10b5-1)
17 Jul 2026
Sold on a plan 3×
$681.54K 26,214 at 26.00
0.2%
Planned (10b5-1)
17 Jul 2026
Honeycutt Jennifer President and CEO
Sold on a plan
$674.22K 7,097 at 95.00
5.4%
Planned (10b5-1)
17 Jul 2026
Kreitzer Anatol Chief Discovery Officer
Sold on a plan 3×
$645.72K 17,173 at 37.60
8.9%
Planned (10b5-1)
17 Jul 2026
DUCA MAURICE J 10% owner
Sold on a plan 4×
$636.46K 3,500 at 181.84
4.1%
Planned (10b5-1)
17 Jul 2026
Kroeger Christopher A. Chief Executive Officer
Sold at will
$635.92K 16,779 at 37.90
1.3%
Not planned
17 Jul 2026
Massaro Michael Chief Executive Officer
Sold on a plan
$588.30K 32,328 at 18.20
1.3%
Planned (10b5-1)
17 Jul 2026
Brase John P President and CEO
Bought
$510.63K 35,000 at 14.59
opened
First buy on file
17 Jul 2026
Sold on a plan
$474.78K 6,000 at 79.13
0.4%
Planned (10b5-1)
17 Jul 2026
HARARI ELIYAHOU ET AL 10% owner · indirect
Bought
$410.99K 61,068 at 6.73
1.9%
17 Jul 2026
SRB CORP 10% owner · indirect
Sold at will
$392.25K 5,159 at 76.03
0.3%
Not planned
17 Jul 2026
GV 2019 GP, L.L.C. 10% owner · indirect
Sold at will
$383.61K 20,534 at 18.68
100%
Sold half or more
17 Jul 2026
PERU RAMIRO G Director
Bought
$366.05K 1,000 at 366.05
10.1%
First buy on file
17 Jul 2026
Hohl Benjamin CHIEF FINANCIAL OFFICER
Sold on a plan 5×
$316.78K 6,018 at 52.64
11.6%
Planned (10b5-1)
17 Jul 2026
Gibbons Mary Lourdes SVP and Chief Legal Officer
Sold on a plan
$313.61K 4,678 at 67.04
2.0%
Planned (10b5-1)
17 Jul 2026
Simmons Christopher C VP, Controller & Treasurer
Sold at will
$303.13K 2,615 at 115.92
43.3%
Not planned
17 Jul 2026
Thiel Frederick G Chief Executive Officer
Sold on a plan
$299.80K 27,505 at 10.90
0.6%
Planned (10b5-1)
17 Jul 2026
MARTINEZ ANGEL R Director
Sold at will
$295.46K 3,740 at 79.00
11.7%
Not planned
17 Jul 2026
Collins Helen Louise CHIEF MEDICAL OFFICER
Sold on a plan 5×
$263.37K 5,000 at 52.67
16.7%
Planned (10b5-1)
17 Jul 2026
Filius Bart Director
Bought
$257.93K 150,000 at 1.72
100%
Largest buy in 3 yrs
17 Jul 2026
Okupe Oluyemi Chief Financial Officer
Sold on a plan
$229.17K 7,163 at 31.99
2.5%
Planned (10b5-1)
17 Jul 2026
MASON JOYCE J EVP and Corporate Secretary
Sold at will
$218.20K 3,488 at 62.56
9.0%
Not planned
17 Jul 2026
Binder Steven B. Director
Sold on a plan
$213.09K 52,485 at 4.06
6.0%
Planned (10b5-1)
17 Jul 2026
RADKE JEFFREY L Co-Founder, CEO · indirect
Sold on a plan
$211.28K 14,777 at 14.30
0.1%
Planned (10b5-1)
17 Jul 2026
Zou Tao Acting Chief Executive Officer
Sold at will 2×
$191.33K 300,000 at 0.64
15.0%
Not planned
17 Jul 2026
BIGLARI, SARDAR 10% owner · indirect
Sold at will
$183.81K 11,000 at 16.71
0.3%
Not planned
17 Jul 2026
TANG KEVIN 10% owner · indirect
Bought
$179.33K 50,945 at 3.52
0.7%
17 Jul 2026
Yi Steven See Remarks
Sold on a plan
$175.10K 12,333 at 14.20
0.5%
Planned (10b5-1)
17 Jul 2026
Khan Salman Hassan Chief Financial Officer · indirect
Sold on a plan
$174.40K 16,000 at 10.90
3.9%
Planned (10b5-1)
17 Jul 2026
Chambers Timothy L Sr VP & Pres - Tools
Sold on a plan
$163.16K 389 at 419.43
1.8%
Planned (10b5-1)
17 Jul 2026
Tyagarajan N. V. Director
Bought
$149.81K 500 at 299.63
16.9%
First buy on file
17 Jul 2026
Sold on a plan 3×
$147.76K 7,073 at 20.89
0.7%
Planned (10b5-1)
17 Jul 2026
Foff Erin Pennock Chief Medical Officer
Sold on a plan
$138.56K 3,656 at 37.90
1.2%
Planned (10b5-1)
17 Jul 2026
Hug Joshua Director
Sold on a plan
$132.61K 5,500 at 24.11
0.2%
Planned (10b5-1)
17 Jul 2026
Wang Yanjun CCO and GC · indirect
Sold on a plan 5×
$123.82K 1,200 at 103.18
3.7%
Planned (10b5-1)
17 Jul 2026
Sable David M. Director
Sold at will
$99.57K 5,779 at 17.23
9.8%
Not planned
17 Jul 2026
Thomson David EVP Genl Counsel & Secretary
Sold on a plan
$97.64K 24,109 at 4.05
2.9%
Planned (10b5-1)
17 Jul 2026
Briggs Andrew J Director
Sold on a plan
$93.18K 3,000 at 31.06
2.6%
Planned (10b5-1)
17 Jul 2026
Mehra Vineet Director
Sold at will
$91.91K 5,000 at 18.38
21.7%
Not planned
17 Jul 2026
Frangou Angeliki See Remarks · indirect
Bought on a plan
$81.26K 1,119 at 72.62
0.0%
Bought on a plan
17 Jul 2026
Lillie James Woodruff Chief Scientific Officer
Sold at will
$78.72K 2,077 at 37.90
0.9%
Not planned
17 Jul 2026
Herrmann Ken Director
Sold at will
$77.26K 3,065 at 25.21
100%
Sold half or more
17 Jul 2026
Wiemann Bradley T Executive Vice President
Sold at will
$76.88K 4,000 at 19.22
3.1%
Not planned
17 Jul 2026
Sold at will 2×
$76.12K 400 at 190.30
1.0%
Not planned
17 Jul 2026
RA CAPITAL MANAGEMENT, L.P. Director · indirect
Bought
$70.54K 7,882 at 8.95
0.0%
17 Jul 2026
Sold at will
$63.20K 5,000 at 12.64
6.5%
Not planned
Showing 15,201–15,250 of 60,080. ← Newer Page 305 of 1,202 Older →